Atsushi Aoyama

Design, Synthesis, and Biological Evaluation of Novel Transrepression-Selective Liver X Receptor (LXR) Ligands with 5,11-Dihydro-5-methyl-11-methylene-6<i>H</i>-dibenz[<i>b</i>,<i>e</i>]azepin-6-one Skeleton

Atsushi Aoyama, Kaori Endo‐Umeda, Kenji Kishida et al. · Journal of Medicinal Chemistry · 2012 · 58 citations · Full text

Drug Target, Cellular Pharmacology, Systems Pharmacology +19

Design, synthesis, and evaluation of potent, structurally novel peroxisome proliferator-activated receptor (PPAR) δ-selective agonists

Jun-ichi Kasuga, Izumi Nakagome, Atsushi Aoyama et al. · Bioorganic & Medicinal Chemistry · 2007 · 41 citations · Full text

δ-Selective Agonists, Biochemistry, Medicine +6

Liver X receptor antagonists with a phthalimide skeleton derived from thalidomide-related glucosidase inhibitors

Tomomi Noguchi‐Yachide, Atsushi Aoyama, Makoto Makishima et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 39 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +12

Co-existence of α-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development

Kosuke Dodo, Atsushi Aoyama, Tomomi Noguchi‐Yachide et al. · Bioorganic & Medicinal Chemistry · 2008 · 38 citations · Full text

Molecular Pharmacology, Signal Transduction, Structural Development +10

Structural development studies of anti-hepatitis C virus agents with a phenanthridinone skeleton

Masahiko Nakamura, Atsushi Aoyama, Mohammed T.A. Salim et al. · Bioorganic & Medicinal Chemistry · 2010 · 37 citations

Phenanthridinone Skeleton, Biochemistry, Viral Hepatitis +10